Treatment with Obecabtagene Autoleucel Results in Durable Response Among Adults with Relapsed or Refractory B-Cell ALL By Ogkologos - December 12, 2024 930 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the FELIX study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Steps towards a smokefree society August 31, 2022 European Lung Cancer Congress 2024 March 7, 2024 Colorectal Cancer Screening: The Silver Lining September 1, 2020 New Blood Test Can Screen For Over 50 Cancers June 7, 2021 Load more HOT NEWS Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant... Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II... ¿Puede el uso de un microondas causar cáncer? Sentinel Lymph Node Biopsy Navigated Neck Dissection Is Not Inferior to...
